SG25093G - Novel fusion protein - Google Patents

Novel fusion protein

Info

Publication number
SG25093G
SG25093G SG250/93A SG25093A SG25093G SG 25093 G SG25093 G SG 25093G SG 250/93 A SG250/93 A SG 250/93A SG 25093 A SG25093 A SG 25093A SG 25093 G SG25093 G SG 25093G
Authority
SG
Singapore
Prior art keywords
gst
enzyme
fusion protein
peptide
fused
Prior art date
Application number
SG250/93A
Other languages
English (en)
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Publication of SG25093G publication Critical patent/SG25093G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG250/93A 1987-05-28 1993-03-06 Novel fusion protein SG25093G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI219587 1987-05-28

Publications (1)

Publication Number Publication Date
SG25093G true SG25093G (en) 1993-06-11

Family

ID=3772204

Family Applications (1)

Application Number Title Priority Date Filing Date
SG250/93A SG25093G (en) 1987-05-28 1993-03-06 Novel fusion protein

Country Status (14)

Country Link
EP (1) EP0293249B1 (de)
JP (1) JPH0681596B2 (de)
AT (1) ATE79902T1 (de)
AU (1) AU607511B2 (de)
CA (1) CA1338903C (de)
DE (1) DE3873989T2 (de)
DK (1) DK169975B1 (de)
ES (1) ES2045115T3 (de)
GR (1) GR3006173T3 (de)
NO (1) NO178894C (de)
NZ (1) NZ224663A (de)
SG (1) SG25093G (de)
WO (1) WO1988009372A1 (de)
ZA (1) ZA883681B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008819A1 (en) * 1989-01-31 1990-08-09 Daratech Pty. Ltd. Vaccine for the preventative treatment of infection of liver fluke in ruminants
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
FR2657883A1 (de) * 1990-02-07 1991-08-09 Transgene Sa
US6077694A (en) * 1990-09-21 2000-06-20 The United States Of America As Represented By The Department Of Health And Human Services Method for over-expression and rapid purification of biosynthetic proteins
WO1993003157A1 (en) * 1991-07-29 1993-02-18 Dana Farber Cancer Institute Plasmids for the rapid preparation of modified proteins
US5596079A (en) * 1991-12-16 1997-01-21 Smith; James R. Mimetics of senescent cell derived inhibitors of DNA synthesis
US6372249B1 (en) 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
WO1993019091A1 (en) * 1992-03-18 1993-09-30 Amrad Corporation Limited Tripartite fusion proteins of glutathione s-transferase
GB9210337D0 (en) * 1992-05-14 1992-07-01 Univ Court Of The University O Feline leukaemia virus vaccine
WO1994017813A1 (en) * 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US5532142A (en) * 1993-02-12 1996-07-02 Board Of Regents, The University Of Texas System Method of isolation and purification of fusion polypeptides
US5480864A (en) * 1993-08-06 1996-01-02 Shiseido Co., Ltd. Modified maxadilan protein, its preparation and use, and DNA encoding the protein
CA2170641C (en) * 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
GB9502489D0 (en) * 1995-02-09 1995-03-29 Animal Health Trust Expression of the non-structural protein NS1 of influenza virus and detection of anti-NS1 antibody in serum
US5800811A (en) * 1995-06-06 1998-09-01 Hall; Frederick L. Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
AU707191B2 (en) 1995-12-28 1999-07-08 Fujirebio Inc. Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said protein
DE19653498C1 (de) * 1996-12-20 1998-07-23 Wolf M Prof Dr Bertling Klonierungsvektor-System mit Fusionssequenz
WO1999006545A2 (en) * 1997-08-01 1999-02-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
EP1005654B1 (de) 1997-08-01 2006-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6077689A (en) * 1997-12-24 2000-06-20 Amgen Inc. Enhanced solubility of recombinant proteins
US6187558B1 (en) 1998-06-24 2001-02-13 Boyce Thompson Institute For Plant Research, Inc. Invertebrate intestinal mucin cDNA and related products and methods
CA2331921A1 (en) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. A novel invertebrate intestinal mucin cdna and related products and methods
GB9821821D0 (en) * 1998-10-07 1998-12-02 Univ Wales Schistomiasis vaccine
US7063837B2 (en) 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
US6632638B1 (en) 2000-11-17 2003-10-14 Amgen, Inc. Enhanced solubility of recombinant proteins using Uracil DNA glycosylase inhibitor
US7094757B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
CA2449747C (en) 2001-06-22 2010-04-13 F. Hoffmann-La Roche Ag Use of fkbp chaperones as expression tool
US6962982B2 (en) 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
ES2255347B1 (es) * 2003-05-21 2007-05-16 Universidad De Vigo Proteina de fusion gst-fucosidasa con actividad enzimatica alfa-l-fucosidasica. proteina recombinante alfa-l-fucosidasa humana.
MY160430A (en) * 2008-12-12 2017-03-15 Univ Sains Malaysia Recombinant antigen for detection of toxocariasis
GB0823550D0 (en) 2008-12-24 2009-01-28 Kinasource Ltd Peptide tag and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3036684A (en) * 1983-07-07 1985-01-10 Genex Corp. Production of bovine calf chymosin
MA20977A1 (fr) * 1986-05-19 1987-12-31 Ciba Geigy Ag Plantes tolerant les herbicides contenant le gene de gluthathione S-Transferase
AU613583B2 (en) * 1986-08-22 1991-08-08 Transgene S.A. Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
CA1339736C (en) * 1986-10-14 1998-03-17 Shionogi & Co., Ltd. Method for preparing fusion proteins

Also Published As

Publication number Publication date
ATE79902T1 (de) 1992-09-15
CA1338903C (en) 1997-02-11
AU1793288A (en) 1988-12-21
DK38189A (da) 1989-01-27
DK169975B1 (da) 1995-04-18
ZA883681B (en) 1989-07-26
DE3873989T2 (de) 1993-02-04
NZ224663A (en) 1990-11-27
JPH01503441A (ja) 1989-11-22
DE3873989D1 (de) 1992-10-01
EP0293249B1 (de) 1992-08-26
NO890325L (no) 1989-03-06
JPH0681596B2 (ja) 1994-10-19
NO178894B (no) 1996-03-18
DK38189D0 (da) 1989-01-27
NO890325D0 (no) 1989-01-26
GR3006173T3 (de) 1993-06-21
AU607511B2 (en) 1991-03-07
EP0293249A1 (de) 1988-11-30
NO178894C (no) 1996-06-26
ES2045115T3 (es) 1994-01-16
WO1988009372A1 (en) 1988-12-01

Similar Documents

Publication Publication Date Title
ZA883681B (en) Novel fusion protein
Brown et al. Structural modifications associated with the change in Ca2+ sensitivity on activation of m‐calpain
DK6488D0 (da) Enzymer
Nakajima et al. Chemical modification of earthworm fibrinolytic enzyme with human serum albumin fragment and characterization of the protease as a therapeutic enzyme
GB2160206B (en) Dna sequence coding for an enzyme cleavage site
HUT43634A (en) Process for expressing vii and ix factor-activity in mammalian celles
DK72593D0 (da) Rekombinant protein
DE3650540D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
AU1283288A (en) Production and purification of a protein fused to a binding protein
CA2202639A1 (fr) Proteines recombinantes de l'hemagglutinine filamenteuse de bordetella, notamment bordetella pertussis, procede pour leur production et leurs applications a la production de proteines etrangeres ou de principes actifs vaccinants
WO1988005081A3 (en) Novel plasminogen activator
AU551490B2 (en) Dna code for protein to suppress abnormal protein degradation
Kalafatis et al. [13] Factor V
NO307384B1 (no) Fremgangsmåte for spalting av proteiner og anvendelse av denne
ATE142263T1 (de) Verfahren zur herstellung von fremdproteinen in streptomyceten